Data mining for drug discovery

- Last updated on GMT

Reel Two, a data mining software company, has licensed its
classification system text and data mining application to
AstraZeneca.

Reel Two, a data mining software company, has licensed its classification system text and data mining application to AstraZeneca.

The Reel Two system uses patent-pending technology to rapidly categorise large volumes of information, show clear links between documents and concepts, or predict future behaviour and patterns from analytical data.

Life science applications include linking classification of published and internal research according to client- specified categories or standard vocabularies, such as the Gene Ontology. Reel Two's classification system is also being used for such tasks as gene sequence and disease data analysis.

"AstraZeneca has a well-founded reputation for adopting cutting-edge technologies to leverage the power of its scientific resources,"​ said Reel Two senior vice-president Nicko Goncharoff. "Reel Two is pleased to be a part of AstraZeneca's

Related topics: Processing